US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

223.00

-4.7500-2.09%

Pre-market: 225.582.58+1.16%09:14 EDT

Volume:804.93K

Turnover:174.45M

Market Cap:585.26M

PE:- -

High:224.85

Open:221.88

Low:208.28

Close:227.75

52wk High:341.93

52wk Low:102.35

Shares:2.62M

Float Shares:2.62M

Volume Ratio:1.53

T/O Rate:30.67%

Dividend:0.91

Dividend Rate:0.41%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors

Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism

Alvotech Gets US FDA Approval For Additional Manufacturing Capacity For Simlandi Biosimilar; Shares Up Pre-Bell

MT Newswires Live

Man Group PLC : Form 8.3 - Spire Healthcare Group Plc

Omega Healthcare to transition 32 facilities in Florida to Pacs Group

Analysts Offer Insights on Healthcare Companies: Encompass Health (EHC), Shattuck Labs (STTK) and Arcus Biosciences (RCUS)

FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®

HanchorBio Secures US FDA Clearance for Solid Tumor Treatment

MT Newswires Live

Aurobindo Pharma Gets US FDA Approval for Perampanel Tablets

MT Newswires Live

Alignment Healthcare (ALHC) Could Be 64% Undervalued As Hoag Deal Expands Orange County Reach

Simply Wall St.

Sonic Healthcare's Funding Risk is Growing

Analysts Conflicted on These Healthcare Names: CSL (OtherCMXHF) and Newron Pharmaceuticals SpA (OtherNWPHF)

HealthCo Healthcare and Wellness REIT Resolves Healthscope Standoff, Resumes Distributions

MT Newswires Live

Optiscan Advances InVue Surgical Imaging Device with U.S. FDA 510(k) Filing

Fisher & Paykel Healthcare Sells South Auckland Land to Health New Zealand for Over NZ$45 Million

MT Newswires Live

Radiopharm Secures FDA Guidance as RAD101 Advances Toward Pivotal Brain Metastases Trial

AdAlta advances EW-001 towards FDA engagement and Australian manufacturing

HealthCo Healthcare & Wellness REIT Declares Quarterly Distribution for September 2026

HealthCo REIT Resolves Healthscope Hospital Leases and Restores Distributions

Fisher & Paykel Healthcare Sells Drury Land to Health NZ for Future Hospital

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/LABU/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":223,"timestamp":1791489600000,"preClose":227.75,"halted":0,"volume":804929,"hourTrading":{"tag":"盘前","latestPrice":225.58,"preClose":223,"latestTime":"09:14 EDT","volume":2108,"amount":474802.27316,"timestamp":1791551661038,"change":2.58,"changeRate":0.01157,"amplitude":0.01487},"delay":0,"changeRate":-0.020856201975850714,"floatShares":2624500,"shares":2624500,"eps":0,"marketStatus":"Pre-Mkt","change":-4.75,"latestTime":"10-09 09:14:42 EDT","open":221.88,"high":224.8479,"low":208.28,"amount":174447835.0605,"amplitude":0.072746,"askPrice":226,"askSize":1,"bidPrice":223.65,"bidSize":100,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791552600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":223,"sharesOutstanding":3074486,"nav":227.52,"aum":597123938.28,"dividendRate":0.0041,"bidAskSpread":0.003146,"preHourTrading":{"tag":"盘前","latestPrice":225.58,"preClose":223,"latestTime":"09:14 EDT","volume":2108,"amount":474802.27316,"timestamp":1791551661038,"change":2.58,"changeRate":0.01157,"amplitude":0.01487},"postHourTrading":{"tag":"盘后","latestPrice":223.66,"preClose":223,"latestTime":"19:57 EDT","volume":4124,"amount":918785.7173,"timestamp":1791503872443,"change":0.66,"changeRate":0.00296,"amplitude":0.008427},"volumeRatio":1.526100709509335,"impliedVol":1.0277,"impliedVolPercentile":0.904},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2624500,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.526100709509335,"shares":2624500,"dividePrice":0.9143,"high":224.8479,"amplitude":0.072746,"preClose":227.75,"low":208.28,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":223,"committee":0.980198,"eps":0,"divideRate":0.0041,"volume":804929,"delay":0,"ttmEps":0,"open":221.88,"prevYearClose":159.39,"prevWeekClose":248.72,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":249.65,"twentyDayClose":266,"sixtyDayClose":277.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673704061","title":"Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704061","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704061?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:30","pubTimestamp":1791199800,"startTime":"0","endTime":"0","summary":"Phase 1/2 APOLLO global clinical trial to evaluate CR-002 in multiple solid tumor types, including non-small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC), on track to ini","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374436/0/en/crescent-biopharma-announces-fda-clearance-of-ind-application-for-cr-002-a-pd-l1-targeted-topoisomerase-inhibitor-adc-for-the-treatment-of-solid-tumors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","NETL","BK4588","ADC","BK4231","BK4080","BK4585","CR","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704113","title":"Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704113","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704113?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":"The Agency reiterated its commitment to addressing the unmet need for treatment of congenital and tumor-related hyperinsulinism and to serving these patient communities On track to report topline resu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374399/0/en/rezolute-announces-fda-recommendation-to-hold-a-pre-bla-meeting-as-a-precursor-to-submitting-a-biologics-license-application-bla-for-congenital-hyperinsulinism.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LU2125154778.USD","LU0128526141.USD","BK4161","LU2360032135.SGD","LABU","LU2125154935.USD","HI","CHI","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673836709","title":"Alvotech Gets US FDA Approval For Additional Manufacturing Capacity For Simlandi Biosimilar; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2673836709","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673836709?lang=en_us&edition=fundamental","pubTime":"2026-10-05 17:52","pubTimestamp":1791193923,"startTime":"0","endTime":"0","summary":"Alvotech  has received US Food and Drug Administration approval for a supplement to the biologics license application for AVT02, marketed as Simlandi in the US, the company said Monday.The move allows drug substance for the product to be manufactured in a second production suite at the company's facility in Reykjavik, Iceland, and further confirms resolution of FDA inspection-related matters at the site.Simlandi is Alvotech's biosimilar to Humira.The company's shares were up 5.9% in premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","ALVO","BK4585","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673045706","title":"Man Group PLC : Form 8.3 - Spire Healthcare Group Plc","url":"https://stock-news.laohu8.com/highlight/detail?id=2673045706","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673045706?lang=en_us&edition=fundamental","pubTime":"2026-10-05 17:45","pubTimestamp":1791193500,"startTime":"0","endTime":"0","summary":"FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374276/0/en/man-group-plc-form-8-3-spire-healthcare-group-plc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4137","LABU","BK4581","LU0128526141.USD","LU0029874061.USD","BK4585","XLV","HCSG","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673067387","title":"Omega Healthcare to transition 32 facilities in Florida to Pacs Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2673067387","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673067387?lang=en_us&edition=fundamental","pubTime":"2026-10-05 17:30","pubTimestamp":1791192634,"startTime":"0","endTime":"0","summary":"Omega Healthcare (OHI) announced that it transitioned 32 skilled nursing facilities in Florida from an operator managed by affiliates of Airamid He...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/omega-healthcare-to-transition-32-facilities-in-florida-to-pacs-group-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/omega-healthcare-to-transition-32-facilities-in-florida-to-pacs-group-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4588","BK4585","SRET","BK4137","SRHR","REZ","BK4581","BK4225","XLV","BK4203","HCSG","OHI","LABU","LU0029874061.USD","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673703019","title":"Analysts Offer Insights on Healthcare Companies: Encompass Health (EHC), Shattuck Labs (STTK) and Arcus Biosciences (RCUS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673703019","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673703019?lang=en_us&edition=fundamental","pubTime":"2026-10-05 16:10","pubTimestamp":1791187816,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Encompass Health (EHC), Shattuck Labs (STTK) and Arc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-encompass-health-ehc-shattuck-labs-sttk-and-arcus-biosciences-rcus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-encompass-health-ehc-shattuck-labs-sttk-and-arcus-biosciences-rcus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","SG9999004303.SGD","BK4588","BK4137","RCUS","LU1983260115.SGD","BK4585","BK4139","XLV","LABU","LU2237957902.USD","LU2237957811.SGD","STTK","BK4185","XBI","LU0054578231.USD","BK4581","HCSG","LU0029874061.USD","SGXZ23171101.USD","EHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673470582","title":"FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®","url":"https://stock-news.laohu8.com/highlight/detail?id=2673470582","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673470582?lang=en_us&edition=fundamental","pubTime":"2026-10-05 16:00","pubTimestamp":1791187200,"startTime":"0","endTime":"0","summary":"Approval enables AVT02 drug substance for U.S. commercial supply to be manufactured in either of Alvotech’s two Reykjavik drug substance suites Further confirms resolution of FDA inspection-related ma","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374199/0/en/fda-approves-additional-u-s-manufacturing-capacity-for-simlandi-alvotech-s-biosimilar-to-humira.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4166","BK4139","GAST","EES","BK4582","MADE","VAI","AMER","ALVO","BBP","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673772375","title":"HanchorBio Secures US FDA Clearance for Solid Tumor Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2673772375","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673772375?lang=en_us&edition=fundamental","pubTime":"2026-10-05 11:55","pubTimestamp":1791172541,"startTime":"0","endTime":"0","summary":"FBD Biologics, a subsidiary of HanchorBio (TPE:7827) has received U.S. Food and Drug Administration clearance for its Investigational New Drug application for HCB303, a trispecific fusion protein bein","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673977484","title":"Aurobindo Pharma Gets US FDA Approval for Perampanel Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2673977484","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673977484?lang=en_us&edition=fundamental","pubTime":"2026-10-05 10:37","pubTimestamp":1791167827,"startTime":"0","endTime":"0","summary":"Aurobindo Pharma  received final approval from the U.S. Food and Drug Administration to manufacture and market Perampanel Tablets in strengths ranging from 2 mg to 12 mg, according to an Oct. 3 exchange filing.The product will be manufactured at Unit-IV of APL Healthcare, a wholly owned subsidiary, and launched in the third quarter of fiscal 2027.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673774730","title":"Alignment Healthcare (ALHC) Could Be 64% Undervalued As Hoag Deal Expands Orange County Reach","url":"https://stock-news.laohu8.com/highlight/detail?id=2673774730","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673774730?lang=en_us&edition=fundamental","pubTime":"2026-10-05 08:19","pubTimestamp":1791159554,"startTime":"0","endTime":"0","summary":"Hoag partnership puts Alignment Healthcare’s Orange County reach in focus\nAlignment Healthcare (ALHC) just announced that its Alignment Health Plan will add Hoag to its network in Orange County, giving Medicare Advantage members in-network access starting January 1, 2027.\nThe agreement includes Hoag’s 1,800 physicians, two acute-care hospitals and a broad set of urgent care and outpatient facilities, tied to select offerings such as the new $0-premium Alignment Health Platinum Preferred HMO...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6034000-choice1-card/1789283981127","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6034000-choice1-card/1789283981127"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/alignment-healthcare-alhc-could-be-64-undervalued-as-hoag-de","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/alignment-healthcare-alhc-could-be-64-undervalued-as-hoag-de","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ALHC","BK4588","BK4581","XLV","BK4585","BK4539","ICBK","BK4154","LABU","BK4211","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673776104","title":"Sonic Healthcare's Funding Risk is Growing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673776104","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673776104?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:56","pubTimestamp":1791154560,"startTime":"0","endTime":"0","summary":"2256 GMT - Funding risk is growing for Sonic Healthcare, says UBS. \"While management has historically deemed U.S. and German funding reforms as unlikely, we believe growing policy momentum makes that view increasingly difficult to sustain,\" UBS says. In the U.S., PAMA reimbursement cuts have been proposed. These would reduce earnings by A$15 million, UBS says. In Germany, the local laboratory association has warned reforms could reduce private billing revenues by 34%. \"Notably, the debate has shifted from whether reform proceeds to how severe the impact will be,\" UBS says. \"We remain more optimistic than the industry's assumptions, modelling a 4% revenue headwind.\" Sonic ended last week at A$18.46. The stock is down 22% from its mid-August high.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4534","LU1863844665.USD","BK4585","LU1829250122.USD","LABU","BK7124","BK4588","LU3187612489.SGD","LU1863844749.USD","BK4118","SHL.AU","XBI","XLV","UBS","IE0034235071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673776102","title":"Analysts Conflicted on These Healthcare Names: CSL (OtherCMXHF) and Newron Pharmaceuticals SpA (OtherNWPHF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673776102","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673776102?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:40","pubTimestamp":1791153611,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on CSL (CMXHF) and Newron Pharmaceuticals SpA (NWPHF). CSL (CMXHF) I...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-csl-othercmxhf-and-newron-pharmaceuticals-spa-othernwphf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-csl-othercmxhf-and-newron-pharmaceuticals-spa-othernwphf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CMXHF","XBI","XLV","BK4585","HCSG","BK4588","LABU","BK4581","NWPHF","LU0029874061.USD","BK4137","BK4007","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673776676","title":"HealthCo Healthcare and Wellness REIT Resolves Healthscope Standoff, Resumes Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2673776676","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673776676?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:33","pubTimestamp":1791153224,"startTime":"0","endTime":"0","summary":"HealthCo Healthcare and Wellness REIT  reached binding agreements covering the remaining 10 Healthscope hospitals owned by the company and its Unlisted Healthcare Fund, clearing the way for distributions to be reinstated, according to a Monday filing with the Australian bourse.The new 20-year leases with Healthe Care, Acurio, and KnG Group are expected to preserve the portfolio's AU$1.35 billion valuation while reducing the largest tenant concentration to 31% from 57% and extending the weighted average lease expiry by 2.9 years to 13.5 years, per the filing.The leases will also provide consumer price index-linked or 3% annual rent escalations, with an around 12% incentive funded from existing liquidity, the filing said.The transition to the new operators is expected to be completed by Nov. 30, with Healthscope continuing to operate the hospitals until then.The company declared a fiscal first quarter distribution of AU$0.015 per unit, in line with its AU$0.06 fiscal 2027 guidance, with ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["8C8U.SI","RNTY","JJJ.SI","CFA.SI","LU0128526141.USD","RJMG","SRT.SI","BPRE","GLS.SI","BK4588","BK4137","BK7149","DFRA","IQRA","BK4585","XLV","PSCF","LABU","SRU.SI","YLDW","CLR.SI","XBI","BK7156","MDIV","BK4581","HCSG","BK6142","LU0029874061.USD","IVRA","HCW.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673776929","title":"Optiscan Advances InVue Surgical Imaging Device with U.S. FDA 510(k) Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673776929","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673776929?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:27","pubTimestamp":1791152862,"startTime":"0","endTime":"0","summary":"Optiscan Imaging Limited ( ($AU:OIL) ) has issued an update. Optiscan Imaging Limited has submitted a U.S. FDA 510(k) application for its InVue pre...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/optiscan-advances-invue-surgical-imaging-device-with-u-s-fda-510k-filing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/optiscan-advances-invue-surgical-imaging-device-with-u-s-fda-510k-filing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588","OIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673765587","title":"Fisher & Paykel Healthcare Sells South Auckland Land to Health New Zealand for Over NZ$45 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2673765587","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673765587?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:16","pubTimestamp":1791152175,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare  agreed to sell 13 hectares of its Karaka Road site in Drury to Health New Zealand for NZ$45.3 million, paving the way for a future hospital to serve South Auckland, according to a Monday filing with the New Zealand and Australian bourses.The site will form part of the company's planned second New Zealand campus, with the remaining land retained for future development, per the filing.Settlement is expected to occur between March and June 2027, subject to certain conditions, while the rezoning application for the wider site remains under review by Auckland Council, the filing said.The transaction will be recognized as an exceptional item, with its financial impact excluded from the previously issued fiscal 2027 earnings guidance, the filing added.The company expects fiscal 2027 net profit after tax of around NZ$525 million to NZ$565 million and operating revenue of about NZ$2.47 billion to NZ$2.57 billion, an earlier filing showed.The company's New Zealand sha","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","NZT.NZ","FPH.AU","BK4585","BK7501","BK4581","BK7007","FNZ.NZ","NZ50G.NZ","T10G.NZ","BK8004","TNZ.NZ","FPH.NZ","XLV","LABU","NZ20C.NZ","NZG.NZ","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673765457","title":"Radiopharm Secures FDA Guidance as RAD101 Advances Toward Pivotal Brain Metastases Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2673765457","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673765457?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:12","pubTimestamp":1791151954,"startTime":"0","endTime":"0","summary":"An announcement from Radiopharm Theranostics Limited ( ($AU:RAD) ) is now available. Radiopharm Theranostics has completed a productive End-of-Phas...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/radiopharm-secures-fda-guidance-as-rad101-advances-toward-pivotal-brain-metastases-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/radiopharm-secures-fda-guidance-as-rad101-advances-toward-pivotal-brain-metastases-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673477651","title":"AdAlta advances EW-001 towards FDA engagement and Australian manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673477651","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673477651?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:02","pubTimestamp":1791151321,"startTime":"0","endTime":"0","summary":"The latest update is out from AdAlta Ltd. ( ($AU:1AD) ). AdAlta has secured Joint Development Committee approval with Shanghai Cell Therapy Group f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adalta-advances-ew-001-towards-fda-engagement-and-australian-manufacturing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adalta-advances-ew-001-towards-fda-engagement-and-australian-manufacturing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","EES","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673763537","title":"HealthCo Healthcare & Wellness REIT Declares Quarterly Distribution for September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673763537","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673763537?lang=en_us&edition=fundamental","pubTime":"2026-10-05 05:58","pubTimestamp":1791151098,"startTime":"0","endTime":"0","summary":"HealthCo Healthcare & Wellness REIT ( ($AU:HCW) ) has shared an announcement. HealthCo Healthcare & Wellness REIT has declared a quarterly distribu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healthco-healthcare-wellness-reit-declares-quarterly-distribution-for-september-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healthco-healthcare-wellness-reit-declares-quarterly-distribution-for-september-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVRA","MDIV","BK4137","BK4585","XBI","BPRE","PSCF","LU0029874061.USD","HCSG","BK4588","BK4581","LU0128526141.USD","RJMG","LABU","REIT","XLV","YLDW","RNTY","DFRA","IQRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673776355","title":"HealthCo REIT Resolves Healthscope Hospital Leases and Restores Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2673776355","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673776355?lang=en_us&edition=fundamental","pubTime":"2026-10-05 05:58","pubTimestamp":1791151090,"startTime":"0","endTime":"0","summary":"An update from HealthCo Healthcare & Wellness REIT ( ($AU:HCW) ) is now available. HealthCo Healthcare & Wellness REIT has executed binding agreeme...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healthco-reit-resolves-healthscope-hospital-leases-and-restores-distributions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healthco-reit-resolves-healthscope-hospital-leases-and-restores-distributions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IQRA","RNTY","BK4585","BK4588","BPRE","MDIV","DFRA","REIT","IVRA","RJMG","XBI","XLV","PSCF","BK4581","LABU","YLDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673775183","title":"Fisher & Paykel Healthcare Sells Drury Land to Health NZ for Future Hospital","url":"https://stock-news.laohu8.com/highlight/detail?id=2673775183","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673775183?lang=en_us&edition=fundamental","pubTime":"2026-10-05 03:47","pubTimestamp":1791143261,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare Corporation Limited ( ($NZ:FPH) ) has shared an announcement. Fisher & Paykel Healthcare has agreed to sell 13 hectares ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-sells-drury-land-to-health-nz-for-future-hospital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-sells-drury-land-to-health-nz-for-future-hospital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","BK4585","XBI","XLV","FPH.NZ","BK8004","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":10,"totalSize":425,"code":"91000000","status":"200"}]}}